Company profile
Veradigm Inc.
OTC: MDRX · Healthcare · Medical - Healthcare Information Services
#199 of 1,418 Healthcare companies by revenue73rd-percentile growth
EA Score
——FH —DQ 44GM —SS 85
v0.1 · 25/100 weight · pillars only
↑ workforce scale, disclosure history · ↓ filing timeliness, growth stability
Methodology →Revenue TTM
$837.2M
Rev growth YoY (TTM)
-39.7%
Net income (FY)
-$291.5M
Employees
2,300
as of 2026-08-10
Market cap
$832.2M
as of 2026-08-10
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$594.4M$594.4M2024
Net income-$291.5M-$291.5M2024
Operating income-$194.7M-$194.7M2024
Total assets$1.4B$1.4B2024
Liabilities$548.3M$548.3M2024
Equity$804.0M$804.0M2024
Revenue trend
FY2024 – FY2024 · USD
FY24
FY24
FY24
FY24
FY24
FY24
FY24
FY24
Revenue by segment
Filed disclosures · FY2022
By product
Provider79%
Payer & Life Sciences21%
By geography
UNITED STATES100%
The read
What is Veradigm Inc.’s revenue?
Veradigm Inc. booked $594.4M in FY2024 revenue, growing 34% year over year — faster than most Healthcare companies we track, at a -49.0% net margin.
Peers · Healthcare
Insmed Incorporated66BTransMedics Group, Inc.77B+UFP Technologies, Inc.80B+Azenta, Inc.75B+Catalyst Pharmaceuticals, Inc.83B+Hinge Health, Inc.47DNeighbors
Cook →Key facts
CEODonald D. Trigg
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersChicago, IL
ExchangeOTC: MDRX
Employees2,300
IPO date1999-07-26
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.